COVID-19 vaccine pricing policy 'unfair': Tamil Nadu CM writes to PM, urges Centre to supply doses
3 years, 8 months ago

COVID-19 vaccine pricing policy 'unfair': Tamil Nadu CM writes to PM, urges Centre to supply doses

Firstpost  

Chennai: Flagging the ‘unfair’ differential price mechanism for COVID-19 vaccines to be procured by the Centre and the state governments, Tamil Nadu said on Monday this places a higher financial burden on states and urged the Centre to supply the doses. In a letter to Prime Minister Narendra Modi ahead of the third phase of inoculation drive covering all over 18 years, from May 1, he suggested Centre “could also explore alternative sources of supply of vaccine including possible imports to ensure that the vaccine rollout takes place across the country smoothly and expeditiously in the coming weeks.” The Union Health Ministry has announced a new policy to be adopted in the next phase of COVID-19 vaccination in the country wherein states have been given the responsibility to procure and administer the vaccine to the people in the age group of 18 to 45, he said. “It is also iniquitous since the state governments have considerably less fiscal resources at their command than the central government.” “Further, since the budgetary provision of Rs 35,000 crore has been made in the Budget Estimates for 2021-22 for the Covid-19 vaccination programme, states have a legitimate expectation that the Government of India would supply the Covid-19 vaccine phase 3,” he added. Pune-based Serum Institute of India, the maker of the most used COVID-19 vaccine in the country, Covishield, had recently announced a price of Rs 600 per dose for private hospitals and Rs 400 per dose for state governments and for any new contract by the central government. Similarly, Bharat Biotech, the Hyderabad-headquartered firm making Covaxin, had priced its COVID-19 vaccine at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals.

Price Covid Centre Vaccine Palaniswami State Governments Supply Dose Governments Tamil Policy Unfair State Governments Tamil  pricing  writes  vaccine  urges  supply  dose  rs  phase  policy  unfair  state  governments  tamil  states  doses  price  nadu  covid19

History of this topic

With State prod, India can be world leader in vaccines
11 months, 2 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

With pooled procurement, drugs cost 82% less
11 months, 3 weeks ago

With pooled procurement, drugs cost 82% less

The Hindu  

In 1995, Tamil Nadu pioneered the centralised procurement and distribution of drugs and medicines to government hospitals across the State. For the first time, a private entity — the National Cancer Grid — has been able to replicate the model and hammer down the cost of high-value, high-volume cancer and supportive care medicines through a pilot pooled procurement programme. The …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

Centre issues advisory to states amid COVID-19 surge
1 year ago

Centre issues advisory to states amid COVID-19 surge

Firstpost  

The central government has asked states to maintain constant vigil over the Covid situation and report and monitor district-wise SARI and ILI cases on a regular basis The Centre on Monday issued advisory to states in view of a recent upsurge in COVID-19 cases and detection of first case of JN.1 variant in India. Centre issues advisory to States in …

Tamil Nadu’s overall immunisation coverage has crossed 95%, says DPH
1 year, 1 month ago

Tamil Nadu’s overall immunisation coverage has crossed 95%, says DPH

The Hindu  

Tamil Nadu’s overall immunisation coverage has crossed 95%. Every year, 9.15 lakh children and 10 lakh pregnant women are covered under the Universal Immunisation Programme, and 3.2 crore vaccines worth nearly ₹10 crore are provided in the State, according to the Directorate of Public Health and Preventive Medicine. Vaccines were available for free in all government health facilities to prevent …

COVID-19 treatments to enter the market with a hefty price tag
1 year, 2 months ago

COVID-19 treatments to enter the market with a hefty price tag

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

COVID-19 treatments to enter the market with a hefty price tag
1 year, 2 months ago

COVID-19 treatments to enter the market with a hefty price tag

Associated Press  

WASHINGTON — The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week. “Pfizer is committed to a smooth commercial transition and is working collaboratively with the U.S. …

Price of lifesaving Covid-19 antiviral Paxlovid expected to rise next year, raising concerns about access
1 year, 2 months ago

Price of lifesaving Covid-19 antiviral Paxlovid expected to rise next year, raising concerns about access

CNN  

CNN — The price of the lifesaving Covid-19 medication Paxlovid is likely to rise next year for most patients as the United States continues to transition out of the emergency phase of the pandemic, sparking concerns among doctors that it will become less accessible. Dr. Eric Topol, a professor of molecular medicine at Scripps Research, called the potential plans for …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 6 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 7 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 7 months ago

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs

News 18  

In the last 75 years, India’s progress as a nation has been both inspiring and impressive. Vaccine PPPs during the Covid-19 pandemic It is during the pandemic that India gained a definite advantage in the global health space, when it administered the first dose of the indigenous Covid-19 vaccine Covaxin, in January 2021. Within a year of the emergence of …

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases
1 year, 7 months ago

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases

Hindustan Times  

India has logged 801 new coronavirus infections, while the active cases have dipped to 14,493 from 15,515, according to the Union Health Ministry data updated on Monday. According to the ministry's website, 220.66 crore doses of Covid vaccine have been administered in the country so far under the nationwide vaccination drive. The active cases now comprise 0.03 per cent of …

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?
1 year, 8 months ago

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?

Live Mint  

It's tough being a pharma company these days.the pharma sector, which once used to be the star of the street, has been witnessing bad times since 2022. Over the last few years, the company has underperformed relative to its peers due to a series of challenges, including oncology clinical failures and missing out on the lucrative market for the first …

At the ready, say officials amid rise in COVID-19 cases in Andhra Pradesh
1 year, 8 months ago

At the ready, say officials amid rise in COVID-19 cases in Andhra Pradesh

The Hindu  

Though the incidence of COVID-19 in Andhra Pradesh is low compared to that of the neighbouring States which have been witnessing hundreds of cases daily, the steady rise in the number of cases reported here has put the officials on their toes. Jagan Mohan Reddy, in a review meeting held recently, asked the health officials to make arrangements to detect …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 8 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

Bihar will buy Covid vaccines in absence of supply from Centre: CM Nitish
1 year, 8 months ago

Bihar will buy Covid vaccines in absence of supply from Centre: CM Nitish

Hindustan Times  

PATNA: Chief minister Nitish Kumar said the state government would buy vaccines against coronavirus on its own to continue inoculating its people as Centre is not providing them to the state, as per a communique from the chief minister’s office on Monday. The communique, however, was silent on the state’s unmet demand for Covid-19 vaccines, how it would buy them …

Centre no longer to procure Covid vaccines for states
1 year, 9 months ago

Centre no longer to procure Covid vaccines for states

Deccan Chronicle  

HYDERABAD: The Centre will no longer follow its practice of procuring Covid-19 vaccines for the states, health minister T. Harish Rao said on Friday, following a decision taken at a meeting on Covid-19 preparedness headed by Union health minister Dr Mansaukh Mandaviya. Harish Rao, in a press note, said the Union minister had advised state governments to procure vaccines from …

Active COVID-19 cases in India rise to 21,179
1 year, 9 months ago

Active COVID-19 cases in India rise to 21,179

The Hindu  

India logged 3,038 new coronavirus cases, while the active cases increased to 21,179, according to the Union Health Ministry data updated on Tuesday, April 4, 2023. The COVID-19 case tally was recorded at 4.47 crore The active cases now comprise 0.05 per cent of the total infections and the national COVID-19 recovery rate was recorded at 98.76 per cent, the …

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs
1 year, 9 months ago

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs

News 18  

It was the Narendra Modi government’s deliberate and concerted decision to deliver free Covid-19 vaccines to everyone in India unlike other countries where vaccines were sold at exorbitant prices, Dr Balram Bhargava, former director general of Indian Council of Medical Research, has said. “The issue of the pricing of vaccines in India was a deliberate effort of the government to …

Moderna expects to price its COVID vaccine at about $130 in the US
1 year, 9 months ago

Moderna expects to price its COVID vaccine at about $130 in the US

Live Mint  

Moderna Inc expects to price its COVID-19 vaccine at around $130 per dose in the U.S. going forward as purchases move to the private sector from the government, the company’s president Stephen Hoge said in an interview on Monday. “There are different customers negotiating different prices right now, which is why it's a little bit complicated,” Hoge said ahead of …

India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

Serum Institute's Cervical Cancer Vaccine to Be Available in Market This Month, Two Doses to Cost Rs 2k
1 year, 11 months ago

Serum Institute's Cervical Cancer Vaccine to Be Available in Market This Month, Two Doses to Cost Rs 2k

News 18  

The Serum Institute’s made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday. According to an official source, Singh has written a letter to the Union Health Ministry mentioning that the price of its HPV vaccine for the private market …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 11 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 11 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

Private hospitals with advance orders to get intranasal COVID-19 shots soon
1 year, 11 months ago

Private hospitals with advance orders to get intranasal COVID-19 shots soon

The Hindu  

Union Health Minister Mansukh Mandaviya and Minister of Science and Technology Jitendra Singh launched first-of-it’s-kind intranasal COVID-19 vaccine iNCOVACC manufactured by Hyderabad-based Vaccine developer Bharat Biotech International Limited on January 26, 2023. It is the world’s first Intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose, administered as nasal drops. The …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 11 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
1 year, 11 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
1 year, 11 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

Administering Of COVID-19 Vaccine By Hospitals Attracts 5% GST: AAAR
1 year, 11 months ago

Administering Of COVID-19 Vaccine By Hospitals Attracts 5% GST: AAAR

Live Law  

The Andhra Pradesh Appellate Authority for Advance Ruling has ruled that hospitals must pay 5% GST when administering the COVID-19 vaccine.The two-member bench of Sanjay Pant and M. Girija Shankar has observed that the administration of the COVID-19 vaccine is not an exempt supply as it is not covered under the definition of "healthcare services." The Andhra Pradesh Appellate Authority …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
1 year, 11 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

Covid-19: Active Cases in Country Dip to 2,149
1 year, 11 months ago

Covid-19: Active Cases in Country Dip to 2,149

News 18  

India logged 104 new coronavirus infections, while the active cases declined to 2,149, according to the Union Health Ministry data updated on Sunday. The active cases comprises 0.01 per cent of the total infections, while the national COVID-19 recovery rate increased to 98.80 per cent, according to the ministry website. According to the ministry’s website, 220.17 crore doses of Covid …

No second Covid-19 booster dose required: Report
2 years ago

No second Covid-19 booster dose required: Report

Live Mint  

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch
2 years ago

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Hindustan Times  

Around 250 million Covid vaccines manufactured by two major Hyderabad-based units – Biological E and Bharat Biotech – are ready for dispatch in the market as soon as orders are received. Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment. Read| Covid drills at hospitals; case count remains low …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
2 years ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
2 years ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint  

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster
2 years ago

Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster

News 18  

A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC is now available on CoWin application for Rs 800, while Rs 325 has been fixed for purchase in government facilities. Provided that private hospitals are permitted to charge up to Rs 150 as an administrative charge for every dose of the Covid-19 vaccine, one dose of this vaccine developed on a …

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
2 years ago

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above according to reports will be available at ₹800+ GST+ hospital charges according to sources. The country’s first intranasal covid vaccine will be rolled out in the fourth week of January as a booster dose for those …

After Slow Start, Demand for Covid-19 Booster Shots Spikes as China's New Wave Triggers Panic in India
2 years ago

After Slow Start, Demand for Covid-19 Booster Shots Spikes as China's New Wave Triggers Panic in India

News 18  

After recording a dull demand for Covid-19 booster shots across months, private hospitals have finally started witnessing footfall and queries to take the jabs. According to Dr Viny Kantroo, Respiratory, Critical Care and Sleep Medicine Consultant, Indraprastha Apollo Hospitals in New Delhi, “With the news of China’s Covid-19 situation, we have seen an uptick in the number of volunteers asking …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha
2 years, 1 month ago

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha

News 18  

There has been no wastage of COVID-19 vaccines in the government buffer stock due to expiry, Union minister Bharati Pravin Pawar informed Lok Sabha on Friday. The central government closely monitors COVID-19 vaccine stocks in states and Union territories so as to ensure their optimal utilisation and minimal wastage, Pawar said in written reply to a question. To ensure utilisation …

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court
2 years, 1 month ago

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court

Live Law  

The Government cannot be held liable to compensate for the deaths occurring due to the administration of COVID-19 vaccines, said the Central Government in an affidavit filed before the Supreme Court.Responding to a petition filed by parents of two girls who died due to the adverse effects of Covishield vaccine, the Union Government submitted that : "The vaccines in use …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Explained | Can vaccine distribution be made fairer?
2 years, 1 month ago

Explained | Can vaccine distribution be made fairer?

The Hindu  

The story so far: The Global Dashboard for Vaccine Equity, a joint effort by the United Nations Development Programme, the World Health Organization and the University of Oxford with cooperation across the UN system, has put out recent data that justifies the vexatious core of the vaccine distribution programme: Only one in four people has been vaccinated with at least …

Pfizer says COVID-19 vaccine will cost $110-$130 per dose
2 years, 2 months ago

Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Associated Press  

Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free. Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

Booster dose: Telangana fares better amid high hesitancy
2 years, 3 months ago

Booster dose: Telangana fares better amid high hesitancy

Deccan Chronicle  

HYDERABAD: As the Central government’s 75-day window for free booster shots has ended, only 41.5 per cent of Telangana's adult population has taken the third dose of Covid vaccine. Meanwhile, Andhra Pradesh has covered the highest population among all states, with 44.4 per cent coverage. Significantly, AP’s coverage of its 60 plus population, who are more at risk from Covid, …

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k
2 years, 3 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint  

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

Discover Related